Alerts

Acne medication warnings further highlight potential risks of mood-related changes and sexual disorders.

Several vitamin and perinatal (including preconception) products are being recalled due to a lack of or excessive levels of potassium iodine.

Takeda Pharmaceuticals Australia has issued a product alert for Vyvanse capsules due to minor packaging errors. The medication is safe to use as prescribed.

Magnum XXL capsules pose a serious risk to your health and should not be taken.

Further examples of counterfeit Ozempic-labelled products have been detected and stopped at the Australian border.

Reynard Health Supplies is conducting a Critical Recall of the above products. A contamination problem has been identified with the products.

More prominent warnings are being added to the Product Information and Consumer Medicine Information for all oral and injectable (systemic) fluoroquinolones to strengthen existing warnings about serious side effects.

Possible risk of learning, communication and behaviour problems in children born to men taking this medicine.

Extra safety information is being added to all montelukast products to highlight the existing warnings about serious behaviour and mood-related changes

Boston Scientific have advised that subsets of ACCOLADE and VISIONIST pacemakers have an increased risk of permanently entering Safety Mode which has limited functionality.

Pharmacists can use a Serious Scarcity Substitution Instrument (SSSI) to dispense Protaphane Penfill human insulin in the place of a Protaphane InnoLet cartridge.

Caruso's Natural Health Pty Ltd is recalling certain batches of WEE LESS, BLOAT EZE and ASHWAGANDHA 7500 due to suspected tampering.

Gold Max Blue capsules pose a serious risk to your health and should not be taken.

Dynamint X tablets pose a serious risk to your health and should not be taken.

There is a potential for insulin leakage with the Accu-Chek Spirit 3.15 ml cartridge system due to a manufacturing problem.

Insulet is advising they have received complaints of Omnipod DASH PDM/controller battery depletion as a result of the 3G network deactivation in the region.

Due to the concerns and difficulties caused by such shortages, we are giving patients and prescribers early notification so that they can plan ahead.

Pharmacists may dispense alternative brands or strengths without a new prescription.

The oral antihistamine promethazine hydrochloride, sold as Phenergan and other generic brands, should not be given to children under 6 years of age.

African Vigorous Max Strength poses a serious risk to your health and should not be taken.

We have tested a further 6 imported, unregistered ivermectin products and found they are counterfeit under the Therapeutic Goods Act 1989.

Ziyinzhuangyang tablets pose a serious risk to your health and should not be taken.

Consumers and health professionals should be aware that counterfeit Ozempic-labelled pens have been imported into Australia. These pens may pose a serious health risk and should not be used. There are clear inconsistencies from the original product to look out for.

We have become aware of an increasing number of cases of liver injury reported in scientific literature, by consumers who had taken products containing Garcinia gummi-gutta.

The TGA has received reports of serious adverse events in infants and children who have been given compounded wind and colic preparations containing Atropa belladonna (belladonna).